Contraceptive Implant Users
common.study.values.description
“The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users”
A prospective, non-inferiority study to evaluate the pharmacokinetic effect of topiramate on serum Etonogestrel (ENG) levels in contraceptive implant users.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Topiramate
Topiramate - Participants will undergo a 6 week titrated regimen of oral topiramate to reach a maximum dose of 400mg per day: Week 1 - topiramate PO 25mg daily Week 2 - topiramate PO 25mg twice daily Week 3 - topiramate PO 50mg twice daily Week 4 - topiramate PO 100mg twice daily Week 5 - topiramate PO 150mg twice daily Week 6 - topiramate PO 200mg twice daily
participant.views.study.view.additional
participant.views.study.view.scientific-title
The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users
common.study.values.clinical-trial-id
NCT03335163
participant.views.study.view.id
9b6EQa
